Abstract
We address the issue of the potential for malignant transformation of cultured mesenchymal stromal cells (MSC) commonly used in clinical cell-therapy protocols and describe the culture conditions under which tumorigenesis is likely to be an extremely uncommon event.
Key Words::
Declaration of interest: The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.